InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Protalix BioTherapeutics, Inc.

PLX Clue Score38
United States Fiscal year ends December CIK 0001006281
$2.78 +2.96% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.78 +139.66% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue9.2Operating income−33.2Net income−29.4Fiscal year 2017Revenue21.1 +129.1%Operating income−34.5Net income−83.4Fiscal year 2018Revenue34.2 +62.4%Operating income−19.3Net income−26.5Fiscal year 2019Revenue54.7 +59.7%Operating income−10.7Net income−18.3EPS, diluted−1.23Fiscal year 2020Revenue62.9 +15.0%Operating income2.7Net income−6.5EPS, diluted−0.22Fiscal year 2021Revenue38.4 −39.0%Operating income−20.5Net income−27.6EPS, diluted−0.62Fiscal year 2022Revenue47.6 +24.2%Operating income−13.0Net income−14.9EPS, diluted−0.31Fiscal year 2023Revenue65.5 +37.5%Operating income10.5Net income8.3EPS, diluted0.09Fiscal year 2024Revenue53.4 −18.5%Operating income3.9Net income2.9 −64.7%EPS, diluted0.04Fiscal year 2025Revenue52.7 −1.2%Operating income−5.5Net income−6.6 −325.2%EPS, diluted−0.08
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 9.2 21.1 34.2 54.7 62.9 38.4 47.6 65.5 53.4 52.7
Growth +129.1% +62.4% +59.7% +15.0% −39.0% +24.2% +37.5% −18.5% −1.2%
Operating income −33.2 −34.5 −19.3 −10.7 2.7 −20.5 −13.0 10.5 3.9 −5.5
Net income −29.4 −83.4 −26.5 −18.3 −6.5 −27.6 −14.9 8.3 2.9 −6.6
Growth −64.7% −325.2%
EPS, diluted n/a n/a n/a −1.23 −0.22 −0.62 −0.31 0.09 0.04 −0.08

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin8.7%Operating margin−360.5%Net margin−319.2%Free cash flow margin−358.2%Fiscal year 2017Gross margin19.0%Operating margin−163.8%Net margin−395.9%Free cash flow margin−52.0%Fiscal year 2018Operating margin−56.4%Net margin−77.3%Free cash flow margin−24.6%Fiscal year 2019Operating margin−19.6%Net margin−33.4%Free cash flow margin−36.5%Fiscal year 2020Operating margin4.3%Net margin−10.4%Free cash flow margin−42.5%Fiscal year 2021Operating margin−53.4%Net margin−71.9%Free cash flow margin−30.6%Fiscal year 2022Operating margin−27.3%Net margin−31.3%Free cash flow margin−53.8%Fiscal year 2023Operating margin16.0%Net margin12.7%Free cash flow margin−3.8%Fiscal year 2024Operating margin7.3%Net margin5.5%Free cash flow margin13.8%Fiscal year 2025Operating margin−10.4%Net margin−12.5%Free cash flow margin−25.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 8.7% 19.0% n/a n/a n/a n/a n/a n/a n/a n/a
Operating margin −360.5% −163.8% −56.4% −19.6% 4.3% −53.4% −27.3% 16.0% 7.3% −10.4%
Net margin −319.2% −395.9% −77.3% −33.4% −10.4% −71.9% −31.3% 12.7% 5.5% −12.5%
Free cash flow margin −358.2% −52.0% −24.6% −36.5% −42.5% −30.6% −53.8% −3.8% 13.8% −25.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−32.1Capital expenditure−0.8Free cash flow−32.9Fiscal year 2017Operating cash flow−10.0Capital expenditure−1.0Free cash flow−11.0Fiscal year 2018Operating cash flow−7.7Capital expenditure−0.7Free cash flow−8.4Fiscal year 2019Operating cash flow−19.4Capital expenditure−0.6Free cash flow−20.0Fiscal year 2020Operating cash flow−26.1Capital expenditure−0.7Free cash flow−26.8Fiscal year 2021Operating cash flow−10.3Capital expenditure−1.5Free cash flow−11.7Fiscal year 2022Operating cash flow−25.0Capital expenditure−0.6Free cash flow−25.6Fiscal year 2023Operating cash flow−1.3Capital expenditure−1.1Free cash flow−2.5Fiscal year 2024Operating cash flow8.7Capital expenditure−1.3Free cash flow7.4Fiscal year 2025Operating cash flow−12.0Capital expenditure−1.6Free cash flow−13.6 −284.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −32.1 −10.0 −7.7 −19.4 −26.1 −10.3 −25.0 −1.3 8.7 −12.0
Capital expenditure −0.8 −1.0 −0.7 −0.6 −0.7 −1.5 −0.6 −1.1 −1.3 −1.6
Free cash flow −32.9 −11.0 −8.4 −20.0 −26.8 −11.7 −25.6 −2.5 7.4 −13.6
Growth −284.4%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash63.3Shareholders’ equity−10.0Fiscal year 2017Cash51.2Shareholders’ equity−29.5Fiscal year 2018Cash37.8Shareholders’ equity−52.9Fiscal year 2019Cash17.8Shareholders’ equity−70.3Fiscal year 2020Cash18.3Shareholders’ equity−27.0Fiscal year 2021Cash39.0Shareholders’ equity−6.0Fiscal year 2022Cash17.1Shareholders’ equity−10.6Fiscal year 2023Cash23.6Shareholders’ equity33.6Fiscal year 2024Cash19.8Shareholders’ equity43.2Fiscal year 2025Cash14.7Shareholders’ equity48.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 63.3 51.2 37.8 17.8 18.3 39.0 17.1 23.6 19.8 14.7
Shareholders’ equity −10.0 −29.5 −52.9 −70.3 −27.0 −6.0 −10.6 33.6 43.2 48.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
9.2 21.1 34.2 54.7 62.9 38.4 47.6 65.5 53.4 52.7
Growth +129.1% +62.4% +59.7% +15.0% −39.0% +24.2% +37.5% −18.5% −1.2%
8.4 15.2 9.3 10.9 10.9 16.3 19.6 23.0 24.3 27.0
0.8 4.0 n/a n/a n/a n/a n/a n/a n/a n/a
Growth +400.7%
30.4 32.2 33.3 44.6 38.2 29.7 29.3 17.1 13.0 19.6
9.4 11.5 10.9 9.9 11.1 12.7 11.7 15.0 12.2 11.7
−33.2 −34.5 −19.3 −10.7 2.7 −20.5 −13.0 10.5 3.9 −5.5
Growth −855.1% −62.6% −240.4%
n/a n/a n/a n/a −6.5 −27.6 −14.4 8.6 4.2 −5.6
n/a n/a n/a n/a n/a n/a 0.5 0.3 1.2 1.0
−29.4 −83.4 −26.5 −18.3 −6.5 −27.6 −14.9 8.3 2.9 −6.6
Growth −64.7% −325.2%
Per share
n/a n/a n/a −1.23 −0.22 −0.62 −0.31 0.12 0.04 −0.08
n/a n/a n/a −1.23 −0.22 −0.62 −0.31 0.09 0.04 −0.08
Growth −55.6% −300.0%
n/a n/a n/a 14.8 29.1 44.1 48.5 67.5 72.5 78.5
n/a n/a n/a 14.8 29.1 44.1 48.5 82.4 81.1 78.5
Growth +96.4% +51.4% +9.8% +70.0% −1.7% −3.1%

† The diluted share count jumps at 2020 and 2021 and 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 3.5% a year over five years.
  • Operating margin is down 14.7 points on five years ago, at -10.4%.
  • A net loss in 8 of 10 years on file.